GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Net Sales Growth History
[Consolidated]
Mar2024 | |
---|---|
Net Sales Growth(%) | - |
What is the latest Net Sales Growth ratio of GUFIC BIOSCIENCES ?
Year | Net Sales Growth |
---|---|
Mar2024 | - |
How is Net Sales Growth of GUFIC BIOSCIENCES Trending?
Years | Net Sales Growth | % Change | |
---|---|---|---|
Mar2024 | 0 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Net Sales Growth ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,853.5 Cr | 0.6% | 10.4% | 8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | 0.6% |
10.4% |
8.9% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses